Chitosan nanoparticles for prolonged delivery of timolol maleate

Drug Development and Industrial Pharmacy

Volumn 33, Issue 11, 2007, Pages 1254-1262

  Agnihotri, Sunil A ^a   Aminabhavi, Tejraj M ^a  

^a KARNATAK UNIVERSITY   (India)

Author keywords

Chitosan; Controlled release; Desolvation; Factorial design; Nanoparticles; Timolol maleate

Indexed keywords

CHITOSAN; NANOPARTICLE; TIMOLOL MALEATE;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; IN VITRO STUDY; INFRARED SPECTROSCOPY; MOLECULAR WEIGHT; PARTICLE SIZE; REGRESSION ANALYSIS; SCANNING ELECTRON MICROSCOPY; ZETA POTENTIAL;

CALORIMETRY, DIFFERENTIAL SCANNING; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG STABILITY; NANOPARTICLES; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TIMOLOL;

EID: 36749063612     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701384942     Document Type: Article

References (33)

1. Aggarwal, D., & Kaur, I. P. (2005). Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. International Journal of Pharmaceutics, 290, 155-159.
2. Agnihotri, S. A., & Aminabhavi, T. M. (2004b). Controlled release of clozapine through chitosan microparticles prepared by a novel method. Journal of Controlled Release, 96, 245-259.
3. Agnihotri, S. A., Mallikarjuna, N. N., & Aminabhavi, T. M. (2004a). Recent advances on chitosan-based micro and nanoparticles in drug delivery. Journal of Controlled Release, 100, 5-28.
4. Aminabhavi, T. M., Agnihotri, S. A., & Naidu, B. V. K. (2004). Rheological studies on stimuli responsive gel forming polymeric solutions for ophthalmic applications and their drug release characteristics. Journal of Applied Polymer Science, 94, 2057-2064.
5. Artursson, P., Lindmark, T., Davis, S. S., & Illum, L. (1994). Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharmaceutical Research, 11, 1358-1361.
6. Bourlais, C. L., Acar, L., Zia, H., Sado, P. A., Needham, T., & Leverge, R. (1998). Ophthalmic drug delivery systems-recent advances. Progress in Retinal and Eye Research, 17, 33-58.
7. Calvo, P., Vila-Jato, J. L., & Alonso, M. J. (1997). Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. International Journal of Pharmaceutics, 153, 41-50.
8. De Campos, A. M., Sanchez, A., & Alonso, M. J. (2001). Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. International Journal of Pharmaceutics, 224, 159-168.
9. De Campos, A. M., Sanchez, A., Gref, R., Calvo, P., & Alonso, M. J. (2003). The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. European Journal of Pharmaceutical Science, 20, 73-81.
10. Di Colo, G., Zambito, Y., Burgalassi, S., Serafini, A., & Saettone, M.F. (2002). Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts based on poly(ethylene oxide). International Journal of Pharmaceutics, 248, 115-122.
11. El-Kamel, A. H. (2002). In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate. International Journal of Pharmaceutics, 241, 47-55.
12. Felt, O., Furrer, P., Mayer, J. M., Plazonnet, B., Buri, P., & Gurny, R. (1999). Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. International Journal of Pharmaceutics, 180, 185-193.
13. Genta, I., Conti, B., Perugini, P., Pavaneto, F., Spadaro, A., & Puglisi, G. (1997). Bioadhesive microspheres for ophthalmic administration of acyclovir. Journal of Pharmacy and Pharmacology, 49, 737-742.
14. Grzeskowiak, E. (1998). Biopharmaceutical availability of sulphadicramide from ocular ointments in vitro. European Journal of Pharmaceutical Science, 6, 247-53.
15. Hornof, M., Weyenberg, W., Ludwig, A., & Bernkop-Schnurch, A. (2003). Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans. Journal of Controlled Release, 89, 419-428.
16. Jarho, P., Jarvinen, K., Urtti, A., Stella, V. J., & Jarvinen, T. (1996). Modified beta-cyclodextrin (SBE7-beta-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits. Journal of Pharmacy and Pharmacology, 48, 263-269.
17. Kaur, I. P., Garg, A., Singla, A. K., & Aggarwal, D. (2004). Vesicular systems in ocular drug delivery: an overview. International Journal of Pharmaceutics, 269, 1-14.
18. Kaur, I. P., & Kanwar, M. (2002). Ocular preparations: The formulation approach. Drug Development and Industrial Pharmacy, 28, 473-493.
19. Ke, T. L., Cagle, G., Schlech, B., Lorenzetti, O. J., & Mattern, J. (2001). Ocular bioavailability of ciprofloxacin in sustained release formulations. Journal of Ocular Pharmacology and Therapeutics, 17, 555-563.
20. Knapczyk, J., Krowczynski, L., Krzck, J., Brzeski, M., Nirnberg, E., Schenk, D., & Struszcyk, H. (1989). Requirements of chitosan for pharmaceutical and biomedical applications. In: Skak-Braek, G., Anthonsen, T., Sandford P. (Eds.), Chitin and chitosan: Sources, chemistry, biochemistry, physical properties, and applications. (pp. 657-663). London: Elsevier.
21. Li, V. H., & Robinson, J. R. (1989). Solution viscosity effects on the ocular disposition of cromolyn sodium in the albino rabbit. International Journal of Pharmaceutics, 53, 219-225.
22. Marchal-Heussler, I., Maincent, P., Hoffman, M., Spittler, J., & Couvreur, P. (1990). Antiglaucomatous activity of betaxolol chlorhydrate sorbed onto different isobutyl cyanoacrylate nanoparticle preparations. International Journal of Pharmaceutics, 58, 115-122.
23. Mendenhall, W., & Sincich, T. (1989). Multiple regression. A second course in business statistics: regression analysis. 3rd Ed. (pp. 141-226.) California: Dellen Publishing.
24. Okhamafe, A. O., & Goosen, M. F. A. (1993). Control of membrane permeability in microcapsules. In: Goosen M. F. A. (Ed.), Fundamentals of animal cell encapsulation and immobilization. (pp. 55-78). Boca Raton, Florida: CRC Press.
25. Ravi Kumar, M. N. V. (2001). A review of chitin and chitosan applications. Reactive and Functional Polymers, 46, 1-27.
26. Ritger, P. L., & Peppas, N. A. (1987). A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. Journal of Controlled Release, 5, 37-42.
27. Rozier, A., Mazuel, C., Grove, J., & Plazonnet, B. (1989). Gelrite®: A novel, ion-activated, in situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol. International Journal of Pharmaceutics, 57, 163-168.
28. Schoenwald, R. D., & Stewart, P. (1980). Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbit. Journal of Pharmaceutical Sciences, 69, 391-393.
29. Thermes, F., Rozier, A., Plazonnet, B., & Grove, J. (1992). Bioadhesion: The effect of polyacrylic acid on the ocular bioavailability of timolol. International Journal of Pharmaceutics, 81, 59-65.
30. Uusitalo, H., Kahonen, M., Ropo, A., & Turjanmaa, V. (1999). The evaluation of efficacy and systemic side effects of topical antiglaucoma drugs: the benefits of improved drug formulation. Journal of Glaucoma, 8, 264-265.
31. Vega, E., Egea, M. A., Valls, O., Espina, M., & Garcia, M. L. (2006). Flurbiprofen loaded biodegradable nanoparticles for ophtalmic administration. Journal of Pharmaceutical Sciences, 95, 2393-2405.
32. Wolfhagen, F. H. J., Groen, F. C., & Ouwendijk, R. J. (1998). Severe nausea and vomiting with timolol eye drops. Lancet, 352, 373.
33. Zimmer, A. K., Zerbe, H., & Kreuter, J. (1994). Evaluation of pilocarpine-loaded albumin particles as drug delivery systems for controlled delivery in the eye I. In vitro and in vivo characterization. Journal of Controlled Release, 32, 57-70.